0
0
12/12/22 at 2:10am
Organization
News-Medical.Net
37 words
0
Comments
Researchers construct a recombinant host-range restricted vaccinia virus Ankara (rMVAs) expressing the spike proteins of several SARS-CoV-2 variants.
You are the first to view
https://www.news-medical.net/news/20221211/Intranasal-recombinant-MVA-based-vaccines-effective-against-SARS-CoV-2-variants-in-mice.aspx
Create an account
or login to join the discussion